7th Fall Education Meeting
11 November to 12, 2005
Dallas, Texas, USA
Synergy: Mechanical and Biological Cardiac Support - Recovery, Replacement, Repair with Cellular Therapy
This meeting has been co-sponsored by the Council on Cardiovascular Surgery and Anesthesia of the American Heart Association
This meeting will explore the potential synergy between the use of mechanical circulatory support and the newer field of cell transplantation. The spectrum of mechanical cardiac therapies now includes not only the utilization of LVAD’s as a bridge to transplantation and destination therapy, but the new promise of LVAD’s used to facilitate the recovery of the diseased myocardium. This meeting presents the participant with a state of the art review of best practices for the utilization of established devices as well as a glimpse into the future of novel newer cardiac pumps that are approaching clinical trials. There will be a practical session devoted to surgical strategies of LVAD implantation in adults and children. The recent preliminary reports of the clinical utility of cardiac cell transplantation opens the door to the use of adjuvant therapies for end-stage CHF that capitalize on the use of LVAD’s to ameliorate the heart failure state. A review of the basic science advances in cell transplantation along with a summary of early clinical trials with stem cells will be presented by a panel of international experts.
The goal of this meeting is to review the current and future status of mechanical circulatory support (MCS) as it pertains to therapy for end-stage cardiac failure and to provide a practical summary of best practices for the surgeon and cardiologist interest in the field of MCS. A second goal is to review the latest basic science reports on the use of stem cells for CHF and review cellular transplant methodologies as well as the latest in clinical trials in patients with cardiac disease.
